These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 6607424)

  • 1. Comparative chromatography of hypothalamic corticotrophin-releasing factors.
    Gillies GE; Puri A; Linton EA; Lowry PJ
    Neuroendocrinology; 1984 Jan; 38(1):17-24. PubMed ID: 6607424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of corticotropin releasing factor (CRF) and arginine vasopressin in median eminence extracts on sephadex gel-filtration.
    Hashimoto K; Ohno N; Yunoki S; Kageyama J; Aoki Y; Takahara J; Ofuji T
    Endocrinol Jpn; 1981 Feb; 28(1):1-7. PubMed ID: 6972867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of rat hypothalamic corticotropin-releasing factor by reversed-phase, high-performance liquid chromatography with synthetic ovine corticotropin-releasing factor as a marker.
    Hashimoto K; Murakami K; Ohno N; Kageyama J; Hattori T; Aoki Y; Takahara J
    Neuroendocrinology; 1983; 36(4):272-6. PubMed ID: 6602951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and characterization of corticotropin-releasing factor and arginine vasopressin in rat hypothalamic nuclei.
    Hashimoto K; Ohno N; Aoki Y; Kageyama J; Takahara J; Ofuji T
    Neuroendocrinology; 1982 Jan; 34(1):32-7. PubMed ID: 6977102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami.
    Ackland JF; Ratter SJ; Bourne GL; Rees LH
    J Endocrinol; 1986 Feb; 108(2):171-80. PubMed ID: 3485168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radioimmunoassay and chromatographic characterisation of CRF-41-like immunoreactivity in hypothalami from several species.
    Linton EA; Lowry PJ
    Neuropeptides; 1982 Oct; 3(1):45-52. PubMed ID: 6984143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticotrophin-releasing factors in the hypothalamus of the developing fetal sheep.
    Currie IS; Brooks AN
    J Dev Physiol; 1992 May; 17(5):241-6. PubMed ID: 1281183
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticotrophin-releasing factor immunoreactivity in the hypothalamus of the rat during the perinatal period.
    Chatelain A; Boudouresque F; Chautard T; Dupouy JP; Oliver C
    J Endocrinol; 1988 Oct; 119(1):59-64. PubMed ID: 3264012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotrophin releasing activity in extracts of the stalk median eminence of Brattleboro rats.
    Gillies G; Lowry PJ
    J Endocrinol; 1980 Jan; 84(1):65-73. PubMed ID: 6987324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A different distribution of corticotropin releasing factor and arginine vasopressin contents in the hypothalamic nuclei after estrogen administration.
    Hashimoto K; Ohno N; Aoki Y; Kageyama J; Takahara J; Ofuji T
    Acta Med Okayama; 1981 Feb; 35(1):37-43. PubMed ID: 6266205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticotropin releasing factor (CRF)-like immunoreactivity in the hypothalamus and posterior pituitary of the goat, bovine, rat, monkey and human.
    Hashimoto K; Murakami K; Hattori T; Niimi M; Fujino K; Ota Z
    Endocrinol Jpn; 1984 Feb; 31(1):7-13. PubMed ID: 6428866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Corticotropin-releasing factor (CRF)-like immunoreactivity in the adrenal medulla.
    Hashimoto K; Murakami K; Hattori T; Niimi M; Fujino K; Ota Z
    Peptides; 1984; 5(4):707-11. PubMed ID: 6333676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of rat corticotrophin-releasing factor-41-related peptide and vasopressin in adrenocorticotrophin-releasing activity from superfused rat hypothalami in vitro.
    Gillies G; Puri A; Hodgkinson S; Lowry PJ
    J Endocrinol; 1984 Oct; 103(1):25-9. PubMed ID: 6090571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of CRF from normal and Brattleboro rat median eminence.
    Pearlmutter AF; Dokas LA; Loeser B; Kong A; Saffran M; Simmons W
    Neuroendocrinology; 1982 Feb; 34(2):99-103. PubMed ID: 7040999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A specific radioimmunoassay for corticotropin releasing factor (CRF) using synthetic ovine CRF.
    Hashimoto K; Murakami K; Ohno N; Kageyama J; Aoki Y; Takahara J; Ota Z
    Life Sci; 1983 Feb; 32(9):1001-7. PubMed ID: 6600808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on the site of origin and molecular form of the extrahypothalamic corticotrophin-releasing factor (CRF) in rats.
    Yasuda N; Yasuda Y
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):145-52. PubMed ID: 2990130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in the hypothalamo-corticotrope axis after bilateral adrenalectomy: evidence for a median eminence site of glucocorticoid action.
    Spinedi E; Giacomini M; Jacquier MC; Gaillard RC
    Neuroendocrinology; 1991 Feb; 53(2):160-70. PubMed ID: 1849620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization and modulation of corticotropin-releasing factor in the neurointermediate pituitary gland.
    Jeandel L; Van Dorsselaer A; Lutz-Bucher B; Koch B
    Neuroendocrinology; 1987 Feb; 45(2):146-51. PubMed ID: 3033535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two distinct corticotrophin releasing activities of vasopressin.
    Buckingham JC
    Br J Pharmacol; 1985 Jan; 84(1):213-9. PubMed ID: 2983801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in the Elution profiles of corticotropin-releasing activity in rat plasma and hypothalamic extracts following high performance liquid chromatography.
    Montague D; Bristow AF; O'Hare MJ; Nice EC; Schulster D
    Neuroendocrinology; 1983 Feb; 36(2):138-43. PubMed ID: 6601246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.